Showing results (191-200 of 667) with videos related to
Sort By:
Pageof 67
Hemasphere|January 25, 2020
Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study GroupS Blais, H Boutroux, M Pasquet, et al.Hemasphere|January 25, 2020
Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-upPanagiotis Baliakas, Bianca Tesi, Ulla Wartiovaara-Kautto, et al.Hemasphere|October 19, 2022
Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.Hemasphere|June 18, 2025
Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based studyKyung Taek Hong, Jung Yoon Choi, Hyery Kim, et al.Hemasphere|June 26, 2025
NK-type large granular lymphocyte leukemia comes of ageGianpietro Semenzato, Antonella Teramo, Gregorio Barilà, et al.Hemasphere|December 31, 2025
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab eraAbdul-Hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart, et al.Hemasphere|December 31, 2025
Health-related quality of life and symptom profile of patients with BCR::ABL1-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational studyGiovanni Caocci, Alessandro Costa, Francesca Palandri, et al.Hemasphere|January 12, 2026
Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 studyMeral Beksac, Tulin Fıratlı Tuglular, Francesca Gay, et al.Hemasphere|April 17, 2025
European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action based on a systematic evidence reviewFrancesca Fioredda, Michail Spanoudakis, Julia Skokowa, et al.Pageof 67